Abstract | During every heartbeat, cardiac valves open and close coordinately to control the unidirectional flow of blood. In this dynamically challenging environment, resident valve cells actively maintain homeostasis, but the signalling between cells and their microenvironment is complex. When homeostasis is disrupted and the valve opening obstructed, haemodynamic profiles can be altered and lead to impaired cardiac function. Currently, late stages of cardiac valve diseases are treated surgically, because no drug therapies exist to reverse or halt disease progression. Consequently, investigators have sought to understand the molecular and cellular mechanisms of valvular diseases using in vitro cell culture systems and biomaterial scaffolds that can mimic the extracellular microenvironment. In this Review, we describe how signals in the extracellular matrix regulate valve cell function. We propose that the cellular context is a critical factor when studying the molecular basis of valvular diseases in vitro, and one should consider how the surrounding matrix might influence cell signalling and functional outcomes in the valve. Investigators need to build a systems-level understanding of the complex signalling network involved in valve regulation, to facilitate drug target identification and promote in situ or ex vivo heart valve regeneration. Wang, H. et al. Nat Rev.
Introduction
As the heart evolved from a single-chamber to a multiplechamber structure, cardiac valves arose to control the unidirectional flow of blood during cardiac cycles. For example, aortic valves open in response to higher blood pressure in the left ventricle than in the aorta, and close when the pressure equilibrates. These valves function in a similar manner to valves in water dams or car engines, but cardiac valves are living tissue with the ability to repair and remodel in response to damage. During an average human life span, heart valves open and close approximately 3 billion times, 1 withstanding various mechanical stresses, including fluid shear stresses and bending stretch. 2, 3 The material composition and structure of cardiac valves confer their robustness and durability. In humans, cardiac valves are made of thin (~500 μm) pliable cusps, and only mitral and tricuspid valves have supporting chordae tendineae and papillary muscles. 4 A close examination of the tissue architecture of an aortic valve reveals three distinct layers of extracellular matrix (ECM), rich in collagens, proteoglycans, or elastin ( Figure 1a) . 4 These ECM proteins impart unique macroscopic mechanical properties to valves, enabling them to withstand tension when closed and flexure when open. For example, the elastin fibres on the flow side of the valves (known as ventricularis) are radially aligned and elastic, which extend when the valves open and recoil when valves close. 5 Proteoglycans in the middle layer, or spongiosa, function as a cushion for absorbing tension and friction between the top and the bottom layers. 4 Finally, the fibrosa layer contains circumferentially oriented collagen fibres, which confer stiffness and strength to the valves. 4 Cardiac valves are composed of valvular endothelial cells (VECs) that line the surfaces of the leaflets, and valvular interstitial cells (VICs) distributed throughout the leaflets (Figure 1b ). Both VECs and VICs maintain tissue homeostasis for the day-to-day function of cardiac valves, as they secrete biochemical signals, matrix proteins, and matrixremodelling enzymes (Figure 1c) . In response to injury or disease, these resident cells often activate in an attempt to repair the valve (Figure 1c ). For example, VECs can undergo an endothelial-to-mesenchymal transition (EMT) to acquire a fibroblast or myofibroblast phenotype that leads to changes in the microenvironmental signals and facilitates tissue regeneration. 6 However, under sustained injury (such as ageing and valve calcification), persistently activated valvular cells can participate in disease progression via inappropriate remodelling of their surrounding ECM. 7 For example, aortic VICs can deposit fibrotic collagen and calcified matrix. 7 These matrix components alter the pliable structure of cardiac valves, leading to a decrease in effective valve opening (known as stenosis), increased blood flow speed, and increased differential pressure across the valves.
■ The interaction between valve cells and their microenvironment signals determine the functional output of cardiac valve tissues; cardiac valve diseases might be caused by a disruption of these interactions ■ In vitro cell culture studies can help understand cardiac valve disease pathobiology, which is enhanced by culturing cells on biomaterials that mimic the native valve cell matrix environment ■ Many biochemical signals regulate pathogenic phenotypes of cells in the valve; however, their effects are dependent on the matrix microenvironment ■ Synthetic biomaterials can be used to understand valve cell regulation by biochemical, biophysical, and other matrix-associated signals, especially related to the development of valvular diseases ■ Understanding the dynamic interplay between microenvironmental signals and valvular cell phenotypes will enable the identification of new therapies and the design of ex vivo tissue engineered valves their differential propensity to develop diseases later in life. For example, aortic and mitral valves are more prone to diseases than other types of cardiac valves. 12 Two main forms of calcific aortic valve diseases (CAVD) exist: 7 aortic valve sclerosis, which involves tissue stiffening, fibrosis, and early calcification; 13, 14 and calcific aortic stenosis (CAS), which involves extensive calcification and reduced valve opening. Aortic valve sclerosis is estimated to be present in ~29% of adults aged >65 years, whereas CAS is present in ~2% of individuals in the same age group. 7, 15 The hearts of patients with symptomatic CAS can undergo pathogenic remodelling towards heart failure unless the valves are replaced with either tissue or mechanical valves. 16 To date, no drug-based therapy is available for treating CAS, other than drugs to manage risk factors, such as high blood pressure or hypercholesterolaemia. 17 Another major valvular disease is mitral valve prolapse, which is characterized by a bulging of the mitral valve cusps into the left atrium and can lead to mitral regurgitation during ventricular systole, and is often treated by surgical repair. 18 Each year, ~98,000 hospital procedures are performed for patients with cardiac valve diseases in the USA alone. 12 These numbers highlight the prevalence of cardiac valve disease and the need for a clear understanding of the disease progression to enable early intervention or drug treatments for the primary pathogenesis.
Cell culture studies have advanced our understanding of valvular diseases. The field has gained considerable insight into the characteristics and associated factors of CAVD using animal models 4, [19] [20] [21] and diseased human valves. 22, 23 However, how the detailed mechanisms regulate cellular phenotypes in these complex models has been hard to determine. In vitro cell culture models can complement animal studies when studying intracellular signalling and enable high-throughput drug screening. However, a major caveat when interpreting these results is that the cells are generally cultured on traditional plastic plates, which are stiffer than an endogenous ECM, the cells are in a polarized environment (that is, the bottom of the cells is adhered to the plastic plates, but the top is free in solution), and biochemical signals can be introduced only as media-soluble factors. To address these shortcomings, new biomaterials have enabled the synthesis of matrix environments that more closely mimic native ECM and enable monitoring of cellular responses in a more physiologically relevant setting. 24 In this Review, we describe how the cellular phenotypes and microenvironmental signalling in valvular diseases are regulated, and highlight developments and applications of biomaterial-based culture systems in facilitating this process. Other investigators have suggested that as many as five different phenotypes of VICs might exist. 25 In this Review, we focus on the two main pathogenic phenotypes-myofibroblast and osteoblast-like-which are strongly associated with progression of CAVD. Differentiation of valvular cells into these pathogenic cellular phenotypes is regulated by their microenvironment, which includes diffusible biochemical signals, physical matrix cues, and cell-cell communication (Figure 2 ). the ventricularis, spongiosa, and fibrosa. In this image, a cross-section of a porcine aortic valve was visualized by second-harmonic generation confocal imaging. Elastin in green, collagen in red. Scale bar: 100 μm. b | Two main cell populations comprise the cardiac valve. VECs, which are CD31 + (green), line the boundaries of the leaflets. VICs reside throughout the valve leaflet. Nuclear staining (DAPI; blue), Scale bar: 100 μm. c | In healthy valves (left), very few VICs and VECs are activated to repair local tissue damage during normal valve function. Collagen fibres are circumferentially aligned, and activated VICs undergo continual turn over into deactivated fibroblasts and other cell fates (such as apoptosis). In diseased valves (right), VICs and VECs are recruited to remodel the tissue, leading to excessive collagen accumulation, a degraded and disarrayed matrix, which in some cases becomes calcified. Valve cells lose the homeostatic equilibrium and remain in an activated state. Abbreviations: VEC, valvular endothelial cell; VIC, valvular interstitial cell.
Cellular phenotypes in CAVD
CAVD is characterized by a progressive thickening, fibrosis, formation of calcified matrix, and new vascularization in the valve leaflets. 7, 14, 19, 26 Mineralized spherical particles (0.1-5.0 μm), with nanostructures similar to those found in other cardiovascular calcification lesions (such as plaque) but distinct from bone mineral, are seen in human valves with different levels of calcification ( Figure 2) . 27 The cause of valve calcification and stenosis is multifactorial; inflammation, oxidative stress, lipid overload, endothelial damage, apoptosis, and trans differentiation of resident cells can all contribute to disease initiation and progression. 28 Owing to the association between lipid overload and CAVD, several clinical trials based on statin-derived lipid-lowering drugs have been carried out. However, in these trials, lowering of lipid levels had limited benefit for preventing CAVD progression. 17, 29 These studies indicate that managing multiple initiating factors of the disease in the correct temporal manner, and targeting downstream molecular and cellular pathology mechanisms, might be necessary for treating CAVD. Valvular cells, VICs, and VECs adopt pathogenic phenotypes in response to the initiating factors of CAVD ( Figure 2b ) and lead to the structural and mechanical deterioration of the tissue. Understanding how these cells function is, therefore, critical for comprehending the molecular and cellular p athology of CAVD before calcification and stenosis develop.
The appearance of myofibroblasts are a primary pathogenic cellular phenotype and an indicator of early CAVD. 8 Myofibroblasts mostly originate from VICs, VECs, resident, or circulating progenitor cells, in response to microenvironmental cues (such as increased matrix stiffness or transforming growth factor-β1 [TGF-β1]) in the diseased valves (Figure 2b) . [30] [31] [32] [33] [34] Myofibroblasts proliferate, migrate to wound sites, express contractile stress fibres (Figure 2b ) to reduce wound size, and produce ECM scaffold proteins and enzymes that remodel the matrix around them. [35] [36] [37] Across human organs, such as skin, 38 liver, 39 lung, 40 kidney, 41 and heart, 42 activation of resident cells into myofibroblasts is a critical aspect of tissue repair and fibrosis. Whereas myofibroblasts are beneficial during the initial phase of tissue healing, persistence of myofibroblasts can lead to fibrosis and matrix protein disorganization. 43, 44 Temporal control of the myofibroblast phenotype is, therefore, likely to be an important aspect of regulating CAVD progression (Figure 2b ). In general, as a wound heals, activated myofibroblasts might undergo apoptosis when the mechanical stress of the wound is relieved (Figure 2b) . 45, 46 Myofibroblasts can also become senescent and be killed by natural killer cells in mice with liver fibrosis (Figure 2b) . 47 In addition, myofibroblasts can deactivate to a quiescent fibroblast state in cultured cardiac VICs or mice with liver fibrosis (Figure 2b ). 48, 49 Another pathogenic phenotype detected in calcified valves is an osteoblast-like phenotype (Figure 2b ). 22 Osteoblasts deposit bone tissue, but whether VICs can truly become osteoblasts is still debated. 50, 51 However, VICs have been observed to acquire many osteoblastlike properties when presented with biochemical and biophysical cues that are known to induce bone formation. [52] [53] [54] [55] For example, 54, 55 human VICs can be induced by bone morphogenetic protein 2 (BMP2) or cyclic stretch to express osteoblast gene markers (such as runtrelated transcription factor 2 [RUNX2] and transcription factor Sp7 [commonly known as osterix]), and alkaline phosphatase activity. 52, 53 Functionally, in ~13% of severely calcified valves, heterotopic ossification has been observed using histological stains of the tissue. 56 While many investigators observe that VICs can undergo in vitro apoptosis-mediated dystrophic calcification, or activate osteogenesis when cultured in osteogenic media, [57] [58] [59] the matrix that the cells produce on a petri dish might not be identical to bone matrix in vivo, indicating that calcification in CAVD might be distinct from that in bone formation. 51 Possibly only a small population of cells can become osteoblasts and contribute to valve calcification in vivo. As with myofibroblasts, these osteoblast-like cells might derive from VICs, VECs, or other types of cells (for example, circulating progenitor cells) in response to local matrix changes (such as increased matrix stiffness and TGF-β1 levels). 6, 33, 34, 58, 60 Whether the same or distinct cells differentiate into myofibroblasts or osteoblast-like cells in valvular disease is still unclear (Figure 2b ). 61 
Soluble molecular signals
Diffusible biochemical cues are acute and potent signals in directing biological outputs of valvular cells and are among the early initiating factors for cardiac valve diseases, including CAVD. Many biochemical signals have been identified by examining diseased human valves.
In early sclerotic lesions of aortic valves, production of inflammatory cytokines, lipoproteins, and endothelial paracrine factors is induced. 14 In advanced lesions and calcified valves, a number of growth factors or their receptors, including TGF-β1, 59 BMP2, 56 vascular endothelial growth factor (VEGF), 62 and low-density lipoprotein receptor-related protein 5, 63 are upregulated. These signalling molecules, secreted by valvular cells and inflammatory, can elicit changes in valve tissue composition and mechanics by acting on the resident VICs and VECs. For example, VECs can secrete paracrine molecules and undergo EMT to become a mesenchymal type cell that mediates tissue repair. 6, 64, 65 The EMT triggered in VECs by pathogenic biochemical factors has common molecular features with cardiac valve development (such as expression of mesenchymal markers and activation of NF-κB); 64, 66 however, further characterization is needed to identify the precise mechanism by which this occurs. In addition, VICs secrete fibrous matrix proteins, matrix metalloproteinases (such as MMP1 and MMP2), biochemical factors, and can differentiate into myofibroblasts or osteoblast-like cells, or undergo cell death-mediated calcification. 7, 25, 67 Proinflammatory cytokines When the homeostasis of valve tissue is disturbed, immune cells (such as macrophages and T cells) infiltrate the damaged area, and secrete various pro inflammatory cytokines, (for example TNF and IL-1β) and MMPs. 14 When human aortic VICs were treated with TNF, it promoted a calcified phenotype, 68 whereas IL-1β increased the secretion of MMPs in these cells. 67 TNF and IL-6 can both enhance EMT in adult porcine aortic VECs (PAVECs), as measured by their invasion into a 3D collagen gel and gene expression. 64 Interestingly, all these cytokines promoted nuclear translocation and activation of NF-κB. 64, 69 As a common signalling target of these proinflammatory factors, NF-κB might be a useful drug target to ameliorate the detrimental effects of these cytokines, which promote diseased VIC and VEC phenotypes. Targeting the NF-κB pathway has been exploited in treating other fibrosis-associated diseases in the liver and lungs, 70, 71 and is an attractive option for treating valve sclerosis. Furthermore, immune cells have been used to deliver cancer drugs; 72 one could, therefore, also take advantage of the localization and secretion of biochemical factors by these immune cells to deliver signals to the site of cardiac valve diseases and prevent development of valvular sclerosis.
Factors associated with endothelium damage
The valve endothelium is a protective layer of cells intimately involved with the homeostasis of valve tissue. 73 VECs are the primary cells in valve endothelium and have some distinct properties compared with aortic endothelial cells, such as alignment and gene expression in response to shear stress. 73 In response to external stimuli (such as haemodynamic changes, oxidized LDL, proinflammatory cytokines, or bacterial toxins), VECs increase their expression of cell adhesion molecules, for example ICAM and VCAM, to promote the adhesion and infiltration of monocytes and lymphocytes to participate in tissue repair. 73 VECs also secrete paracrine factors, including nitric oxide, endothelin-1, and C-type natriuretic peptide. Most biochemical factors secreted by VECs (except endothelin-1) function to reduce the patho genic phenotypes of VICs. For example, nitric oxide reduces both myofibroblast and osteoblast differentiation of PAVICs, 74 probably through the canonical cGMP pathway to inhibit myofibroblast activation. 74, 75 Similarly, C-type natriuretic peptide treatment on PAVICs inhibits actin, aortic smooth muscle (ACTA2, commonly known as α-smooth muscle actin, α-SMA) expression, collagen gel contraction, and blocks calcific nodule formation and expression of osteogenesis-related genes under osteogenic culture conditions. 76 By contrast, endothelin-1 is profibrotic and promotes contraction of valve cusps in vitro. 77 If the production of these protective molecules by cardiac valve endothelium can be manipulated in vivo, this modulation might lead to a therapy that controls or reduces VIC pathogenic phenotypes.
TGF-β superfamily TGF-β1 is a potent profibrotic chemokine and is implicated in fibrosis of organs in the body, including cardiac valves, lungs, kidneys, and liver. 78 Elevated TGF-β1 levels have been detected in human calcified valves and are likely to be derived from macrophages and resident mesenchymal cells. 79 Based on in vitro cell culture studies, TGF-β1 induces myofibroblast activation of VICs, which is characterized by stress fibres expressing ACTA2 and collagen deposition, 30, 43 and can promote apoptosis-associated calcification in VICs. 59 In vitro TGF-β1 induces EMT-mediated invasion of VECs into collagen gels. 64 Furthermore, TGF-β1 promotes secretion of profibrotic cytokines to change the local profile of biochemical signals. 78, 80 All these effects exacerbate fibrotic lesion development mediated by valvular cells, infiltrated immune, and progenitor cells. TGF-β1 can act through either canonical (mothers against decapent aplegic homologue 2 and 3) or noncanonical (focal adhesion kinase 1, phosphatidylinositol 4,5-bisphosphat e 3-kinase, mitogen-activated protein kinase 11) signalling pathways to promote different cellular functions. [81] [82] [83] In addition to TGF-β1, BMP2 is also elevated in human stenotic valves, which can lead to osteogenic differentiation of resident cells by stimulating the expression of pro-osteogenic genes, such as RUNX2 and BGLAP (which encodes osteocalcin). 54 Many other biochemical signals that might be associated with CAVD are currently being investigated, including lipids, 84, 85 angiotensin II, 86, 87 reactive oxygen species, 88 Wnt, 89 VEGF, 62 fibroblast growth factor 2, 90 and 5-hydroxytryptamine. 91, 92 These biochemical factors can activate different intracellular signalling pathways or gene expression to regulate VICs and VECs in a spatial, temporal, and dose-dependent manner. 4 However, many of these studies were designed to investigate the effect of the biochemical signals in isolation from the native matrix environment. 87, [90] [91] [92] These studies have provided valuable insights into signalling regulation on valvular cells, but the response of VICs and VECs to the many signals often depends on the context of the microenvironment in which they reside (such as, matrix c omposition and stiffness).
The extracellular matrix
The ECM is a complex environment, rich in biochemical and biophysical factors that can direct cellular function. 24, 93 ECM proteins interact with cells through specific integrin-binding epitopes, which subsequently activate intracellular signalling and regulate cellular phenotypes. 94 In addition, matrix molecules such as proteoglycans can locally sequester biochemical factors, and consequently, the ECM serves as a reservoir of biological signals that can be released on demand. 95 Simple delivery of biochemical factors as soluble media additives, therefore, might not fully simulate the effects of biochemical factors presented in cardiac valve tissue, where these signals are often bound to matrix proteins or might need to diffuse through a dense matrix. The ECM also maintains basal cellular tension through its mechanical properties, transmits external mechanical forces, often presents distinct topographical features, and renders positional information to cells. 96, 97 Pioneering experiments with cells cultured using hydrogels composed of natural ECM proteins (such as collagen and fibronectin) or synthetic biomaterials have revealed that the culture substrate can also regulate cellular function. For example, muscle satellite cells have an increased capacity to self-renew and regenerate damaged muscle tissues when cultured on laminin-coated hydrogels with a matrix elasticity that closely matches their native niche. 98 Similarly, VICs can better maintain an unactivated fibroblast phenotype when cultured on hydrogels that mimic elasticity of the ECM, compared with plain plastic plates. 99 This finding suggests that the culture microenvironment should be controlled to preserve the native phenotype of VICs. Moreover, controlling the microenvironment might be especially important when studying VIC responses to exogenous signals, which might not be apparent if the cellular p henotype is altered by culture on plastic plates.
The cellular microenvironment can also influence cell fate determination when presented with biochemical signals. For example, PAVICs do not form calcified nodules on soft poly(ethylene glycol) (PEG) hydrogels even when coated with fibrin, which can increase VIC calcification on plastic plates. 100 Furthermore, TGF-β1 did not activate the myofibroblast phenotype of VICs on compliant collagen or PEG gels, 32, 49 indicating that a stiff matrix environment might be a requirement of myo fibroblast activation in valve cells. Culture on plastic plates provides only a 2D surface for growing cells, which can unnaturally polarize them ( Figure 3) ; whereas most cell types residing in tissues, including VICs, are embedded in a 3D matrix environment. When cells are cultured in 3D bioscaffolds, they have different focal adhesion structures, as well as mechanotransduction, polarity, and signalling responses to growth factors, from those cultured on 2D substrates (Figure 3) . 101 ECM proteins in healthy valves ECM proteins in a healthy cardiac valve promote valve cell survival and function. 102 PAVICs isolated from different layers of ECM have distinct levels of myofibroblast activation in response to environmental signals, 103 indicating that ECM composition and mechanical properties are likely to regulate the basal phenotype of these cells.
Collagens comprise ~90% of the ECM in the cardiac valve. 102 In a healthy valve, collagen forms fibrils by bundl ing procollagen triple peptide helices in the extracellular space, and this structure confers strength to the fibrosa in the direction of its alignment. 102 However, in CAVD, excessive collagen deposition and disrupted alignment can lead to increased matrix stiffness but reduced flexibility as the valve opens and closes ( Figure 1) . 7 Fibrillar collagen coated onto plastic plates can inhibit myofibroblast activation and calcific nodule formation of PAVICs compared with uncoated plates, 104, 105 indicating that collagen might help to inhibit pathogenic differentiation of VICs. Conversely, collagenbased gels with different stiffness can promote calcific nodule formation in PAVICs, via osteogenic or myofibrogenic mechanisms, when cultured in calcifying media on 2D substrates. 57, 106 These results suggest that collagen can regulate the cellular phenotype through both biochemical and biophysical properties, which correlates with observations that the initiation of calcification occurs more often in the fibrosa of valves than the other two layers in the valve. 106 In addition, 3D in vitro collagen gels can promote VIC adhesion, spreading, proliferation, and matrix synthesis. 102, 107, 108 Collagen gels are a simple, but robust, platform for culturing valvular cells in vitro, which has led to growing interest in other matrix systems that might permit investigators to alter the cellular m icroenvironment to study disease progression.
Proteoglycans and glycosaminoglycans (GAGs) (such as versican and hyaluronic acid) are also abundant in the middle layer of the valve (the spongiosa). 109 These proteins do not provide the same stiffness of collagen; however, they are highly polar and attract water, which functions as a lubricant cushion to absorb compressive stresses in the tissue. 110 In addition, proteoglycans and GAGs can help to sequester or function as co-ligands for growth factors. 95 In CAVD, proteoglycans and GAGs might contribute to atherosclerotic lesion development by retaining lipids and attracting inflammatory cells in the valve ECM. 109 Managing the synthesis and structure of proteoglycans and GAGs has, therefore, been proposed as a promising therapeutic target to treat CAVD. 109 The GAG, heparin, is a potent activator of PAVICs when coated on plastic plates, promoting the formation of myofibroblasts and calcified nodules. 111, 112 However, heparin is also known to interact with growth factors such as FGF2 and TGF-β1, 113 so understanding GAG regulation of VIC phenotypes is complex. Another type of GAG is hyaluronic acid, which constitutes a matrix scaffold to maintain VIC survival, growth, and ECM protein secretion, to enable the study of proteoglycan and GAG effects. 114, 115 Interestingly, hyaluronic acid degradation products from a PEG-hyaluronic acid-based hydrogel can promote elastin synthesis in PAVICs, 116 indicating that this matrix cue can be fine-tuned to regulate VIC secretory properties and might be beneficial for valve tissue engineering strategies. Given that hyaluronic acid can bind to cell surface receptor CD44, 117 and interact with other growth factor receptors, 118 further investigation is needed to determine whether the biological activity of hyaluronic acid-based biomaterials is mediated by CD44 or other interacting growth factor receptors.
Elastin is the major ECM component on the flow side of aortic valves and extends as a fibrous, interweaving structure deep into the valve spongiosa. 119 While the effects of presenting the elastin protein to VICs have not been investigated in detail in vitro, mice with elastin haplo insufficiency develop aortic regurgitation with increasing age and VICs have reduced expression of genes that are associated with TGF-β1-induced fibro genesis. 120 This result indicates that elastin is an important component of the valve and regulates gene expression of VICs. Elastin degradation and fragmentation have also been detected in diseased valves, 121 and treatment with fragments of degraded elastin can induce calcification phenotypes in rat dermal fibroblasts in vitro. 122 Other ECM proteins, such as fibronectin, periostin, and vitronectin also help to maintain the mechanical integrity of the valves and regulate cellular functions. 102 Interestingly, decellularized valvular matrices seeded with valve progenitor cells have been exploited as scaffolds for clinical valve replacement; for example, this approach has been used successfully to replace pulmonary valves in sheep and humans. 123, 124 In vitro ECM-based culture systems are a promising advance for understanding VICs, but these platforms are not without limitations. ECM proteins in healthy valves are easily accessible materials and support the basic biological functions of VICs; however, their biochemical and biophysical properties are usually intertwined and difficult to determine. Furthermore, in developing clinically relevant tissue constructs for valve replacement, naturally-derived scaffolds can encounter problems with batch-to-batch manufacturing variations and interspecies immunogenic issues with the hosts. 125 Synthetic biomaterials and the valve ECM Synthetic biomaterials such as those made from PEG or poly(vinyl) alcohol, have been used as substrates to understand the effects of matrix reserved cues on VICs. 126, 127 These hydrogels can be synthesized under ambient, mild conditions for cell culture and encapsulation. Synthetic ECM mimics, can be used as basic permissive environments that allow cells to develop in 2D and 3D culture in a passive manner, or as active promoting niches that present specific biological cues (for example, adhesive ligands, MMP degradable sequences, and locally sequestering growth factors). 128 Synthetic biomaterial scaffolds are often engineered to have elastic properties similar to those measured in many soft tissues (Figure 3) . 129 VICs not only survive in these synthetic biomaterials, but can actively remodel the gel environments and respond to chemical signals such as TGF-β1 by producing more collagen matrix. 130, 131 However, a major challenge in developing synthetic ECM scaffolds for cell culture is to determine those signals that are necessary to create an environment that supports basic cell function, while permitting control of the material to dissect the complexity in matrix signalling.
Biochemical signals in the ECM scaffold
The ECM can regulate diffusible biochemical signals via covalent or noncovalent interactions. 93 Matrix proteins also have inherent peptide domains that can directly bind with integrins on cell surfaces, growth factors, and other ECM proteins, or can be cleaved by ECM-remodelling enzymes. 93 For example, collagen binds integrins, the discoidin domain receptors, or other ECM proteins through different peptide sequence domains. 132, 133 To recapitulate these different ECM functional domains in artificial bioscaffolds, peptides are now routinely used as surrogates for whole proteins, and can be helpful in ascertaining how matrix cues regulate valvular cells. For example, ECM-derived adhesive peptides (such as RGDS derived from fibronectin, and YIGSR derived from laminin) partially recapitulate the effects of ECM proteins on VIC calcification phenotypes when cultured on plastic plates. 105 This result indicates that integrin binding is partially responsible for ECM-regulated VIC calcification. Plastic plates nonspecifically adsorb many serum proteins and some investigators have, therefore, exploited peptide-functionalized hydrogels modified with different ECM adhesive peptides (RGDS, VGVAPG derived from elastin, and P15 derived from collagen) to study how matrix composition regulates VIC activation and ECM deposition. 126 When culture substrates had a basal level of RGDS to promote PAVIC adhesion, adding the collagen-derived P15 peptide sequence led to an increase in ACTA2 levels (Figure 3b, blue bars) . 126 Synthetic hydrogels also provide a greater degree of biochemical signal spatiotemporal control than traditional culture methods. Methods have been developed to tether biomolecules to hydrogels, maintain their activity, and examine their effects on stem-cell functions. [134] [135] [136] These approaches can be easily adapted to VICs to present active growth factors in a locally and temporally controlled manner. However, in an in vivo setting, secreted biochemical factors might remain bound to the matrix until they are passively released, or activated mechanically or enzymatically. 137, 138 For example, rat lung myofibroblasts can activate TGF-β1 mechanically by contracting their matrix. 137 As one example of controlling interactions between growth factors and matrices, investigators incorporated peptides with different sequences and structures with affinity for FGF-2 to control its local presentation in hydrogels. 139 In the future, the sequential release of multiple growth factors might enable concentration gradients that elicit differential cellular responses to better study how growth factors contribute to CAVD development and tissue regeneration.
Biophysical signals in the ECM scaffold
The ECM itself can regulate cells based on its bio physical material properties, such as elasticity. 129 Elasticity is a physiologically meaningful material property relevant to disease progression, because native tissues stiffen as fibrosis develops. A simplified measure of matrix elasticity is the ratio of an applied stress divided by the deformation of a material (strain) when a tensile stress is applied, and is often reported as a Young's modulus (E). 140 Traditional plastic plates for cell culture have an E of ~3 GPa, which is many orders of magnitude higher than the stiffness of valve leaflets, 140 which has been reported in the literature as ranging from 0.1 kPa to 2 MPa. 3, [141] [142] [143] [144] This variability might be due to anisotropic properties of valves, differences in measurement methods, and strain levels used for calculation. Owing to this disparity in mechanical properties, synthetic hydrogels are designed to mimic the elasticity range of valve tissue, and assess the specific effects of matrix elasticity on VIC phenotypes (Figure 3) . In one study, investigators created a PEG-based hydrogel with an E gradient of 7-32 kPa. 138 In this environment >80% of PAVICs formed myofibroblasts near the stiff region (32 kPa), and <10% differentiated into myofibroblasts near the soft end (7 kPa) after 3 days of culture in low serum media (Figure 3c) . 145 This study is an excellent example of how one might engineer different elastic properties to direct VIC population phenotypes.
The elasticity of the culture environment can regulate myofibroblast activation of fibroblasts isolated from different tissues, including liver, skin, and lung; very similar thresholds of activation have been observed to that of VICs. [145] [146] [147] [148] Matrix elasticity (in combination with inductive biochemical signals) can also regulate calcific nodule formation, 57 proliferation, 49, 149 and apoptosis of fibroblasts. 146, 149, 150 Many of these studies have been carried out by culturing cells on 2D substrates with different elastic moduli. However, one group of researchers have investigated the mechanobiology of VICs in 3D culture and found that cells cultured in stiff environments, and in the presence of TGF-β1, were induced to myofibroblasts and exerted high tension on their 3D matrix. 151 Matrix elasticity can also modulate cellular responses to biochemical factors. For example, PAVICs have increased myofibroblast activation in response to TGF-β1 on poly(acrylamide) gels coated with fibrillar collagen when E was >22 kPa, but did not respond to TGF-β1 when E was <11 kPa. 147 Matrix elasticity might act via the transcriptional coactivators, Yorkie homologue (also known as Yes-associated protein; YAP) and WW domain-containin g transcription regulator protein 1 (commonly known as TAZ); both proteins can function as sensors of matrix elasticity in human mesenchymal stem cells. 152 YAP and TAZ are also present in VICs and become localized to the nucleus with increasing matrix elasticity. 153 Finally, matrix stiffness might regulate intracellular biochemical signalling of cells through mechanosignalling at focal adhesions. 99, 154 Matrix stiffness has been recognized as an important biophysical cue that can regulate diverse cellular functions, 98, 129 but other matrix biophysical signals including nanotopography, 97 anchoring of matrix fibres, 155 and degradation-mediated cellular traction, 156 should also be considered as contributing factors in directing cell fate. Although beyond the scope of this Review, cells residing in valves are highly responsive to changes in haemodynamic profiles and external mechanical stress (such as cyclic stretch, pressure, shear stress), and have been excellently reviewed elsewhere. 3, [157] [158] [159] Mechanical stresses experienced by tissues are transmitted to cells and, therefore, should be carefully studied to facilitate the design of tissue-engineered heart valves that respond positively to in vivo haemodynamics. 160, 161 Cell-cell interactions Cell-cell interactions are important regulators of tissue homeostasis and valvular disease progression and include both homotypic and heterotypic interactions (that is, VIC-VIC, VIC-VEC, and VEC-VEC interactions). In VIC-VIC adhesion, cadherin-11 is one of the most abundant cadherins in PAVICs and mediates cell-cell junctions between myofibroblasts. 162 Cadherin-11 can also promote calcific nodule formation in cultured VICs. 163 How ever, while antibodies against cadherin-11 can amelio rate fibrosis in synovium 164 and lung, 165 they have not been tested for valvular sclerosis. VEC-VEC junctions are important to maintain the integrity of the valve endothelial lining, but can be disrupted when VECs undergo EMT in response to inflammatory cytokines 64 and other disease risk factors, such as altered shear stress. 166 In the healthy valve tissue, VECs are largely in contact with VICs near the boundary of the valves, and signal between each other via paracrine signals. 4 These cells must be in close proximity for paracrine signals to function correctly; therefore, the spatial position of the cells is important. To create a culture platform that closely mimics the relative geometry of VICs and VECs in a valve, investigators have encapsulated PAVICs in collagen gels with PAVECs seeded on the surface. 167 PAVECs can stimulate PAVICs to adopt a quiescent phenotype, with reduced ACTA2 expression or proliferation. 167 In addition, another group of investigators have used magnetic levitation to build in vitro microtissue blocks of PAVICs or PAVECs, and cocultured them by stacking the PAVEC block on top of PAVICs. 168 These cocultured cells maintained aspects of the healthy phenotypes of both cell populations and permitted in situ matrix deposition. 168 Other investigators have designed a culture system whereby PAVICs were seeded on PEG hydrogels fabricated in a transwell membrane and the PEG tensile E can be controlled to study its influence on cell-cell signalling. 75 Interestingly, using this culture system, PAVECs induced ~70% reduction in myofibroblast activation when PAVICs were cultured on soft gels (~3 kPa), but ~20-30% of reduction in myofibroblast activation on stiff gels (~27 kPa). 75 This differential response was partially dependent on nitric oxide-mediated signalling. 75 Future experiments might identify those biochemical and matrix biophysical signals that regulate these VIC-VEC interactions and how. Coculture systems that preserve the spatial proximity of VICs and VECs are versatile and should be more widely used by investigators examining complex interactions in cardiac valve biology. Such experiments might reveal novel mechanisms of regulation that can otherwise be obscured or modified if cells are simply cultured together on plastic substrates or without the ability to control the cell's spatial proximity.
Dynamic culture systems
The process of cell remodelling is more dynamic during CAVD development than in healthy valves. In diseased valves, local cell populations change their phenotypes, secrete varying amounts and types of cytokines, and actively remodel the ECM (Figure 4) . 7, 14 To recapitulate these dynamic signals and understand the temporal regulation of cellular phenotypes, we need to exploit advanced multifunctional culture substrates that allow manipulation of biochemical and biophysical matrix cues on demand. For example, biomaterials that permit control over their material properties in both space and time offer great potential for understanding the basic biology of matrix signalling and in facilitating tissue regeneration. 128 To study the effects of increasing concentration of biochemical signals on a cell's microenvironment, some investigators have used light-initiated chemistry to pattern streptavidin or barnase (which bind biotin and barstar respectively) into a 3D agarose gel. 169 Growth factors linked to either biotin or barstar can then be introduced to the gel and bind to these prepatterned positions. 169 This approach enables the delivery of two different biochemical signals, both temporally and spatially, in a manner that preserves their activity. To modify biochemical ligands involved in cell adhesion, investigators have also patterned cell adhesive peptides modified with photolabile groups (o-nitrobenzyl ether) into a 3D PEG hydrogel and then specifically cleaved them using light with a wavelength of 365 nm to remove the signals at defined loci and times. 170 To achieve recurrent patterning in the matrix microenvironment, Gandavarapu et al. developed an allyl sulphide functionalized PEG hydrogel system in which one can pattern and exchange different biochemical cues modified with a sulphhydryl functional group multiple times. 171 These systems might be used to study how locally patterned TGF-β1 or other biochemical signals regulate VIC phenotypes in 3D, and importantly, how cells can revert to a homeostatic state with their surrounding matrix when levels of the activating signal are modulated.
Synthetic bioscaffolds can also be used to study how mechanotransduction can influence cell states, For example, a photoresponsive PEG hydrogel has been developed that can be softened upon exposure to light and in the presence of cells. 172 Exploiting this dynamic substrate, investigators have shown that PI3K/Akt activity decreased in response to reduced matrix elasticity (from 32 kPa to 7 kPa), which consequently inhibited the differentiation of VICs to myofibroblast. 99 Using a similar photoresponsive PEG hydrogel, researchers have created topographical patterns at the micrometre scale on soft PEG hydrogels (~3 kPa), which induce parallel PAVIC alignment according to the patterned features and myofibroblast activation. 173 This result indicates that both stiffness and topography of the matrix affect VIC differentiation. Biomaterials that stiffen over time have also been developed and used to direct hepatic myo fibroblast activation. 174, 175 These materials mimic aspects of the matrix stiffening process during the development of valvular sclerosis, and together, should prove useful to dissect the signalling pathways involved in activating or deactivating cells in response to matrix elasticity changes. However, in our experience, these substrates do not completely recapitulate in vivo tissue remodelling, but continual improvements are being made to mimic the native ECM more closely. Nevertheless, in vitro reconstituted biomaterials enable the understanding of specific and combined effects of different ECM remodelling on c ellular phenotypes.
Future perspectives
If we can understand how valve cells and microenvironmental signals mutually regulate each other, we might be able to ameliorate valvular disease progression at an early stage by targeting these interactions. Furthermore, by directing cells to deposit a specific ECM composition in an engineered scaffold, one might be able to create viable replacement valves for paediatric patients with the potential for further in situ growth. To achieve such goals, understanding the mechanisms of regulation between cells and the ECM in both normal and diseased valves is required. Given the role of VICs in mediating tissue repair, we need to better define their basal, myofibroblast, and osteo blast phenotypes. VICs might become activated when they are isolated from their native matrix; 99 therefore, determining how we can maintain their native pheno types by designing appropriate culturing substrates would be beneficial. Importantly, measuring how differential gene expression contributes to ECM remodelling, stiffening, and other biological function in valvular tissue function is also needed.
Furthermore, how the temporal presentation of biochemical signals (such as TNF and TGF-β1) regulates VEC and VIC function as CAVD progresses, and their interaction in regulating intracellular signalling, is unclear. High-throughput screening methods might improve our understanding of the roles of growth factors in directing particular cellular functions (for example, via contraction or matrix protein production). Importantly, these factors must be studied and characterized in the context of a suitable microenvironment, to understand how growth factor signalling and availability can be coupled to the matrix.
Future studies should also take advantage of synthetic biomaterials to determine how individual and coordinated signals of ECM elasticity, adhesion, and biochemical interactions influence valve cell function. In addition, biomaterials that can be dynamically altered to change their biophysical and biochemical properties will enable investigators to mimic the ECM changes seen during disease progression to study the underlying molecular and cellular mechanisms. Furthermore, using animal models of CAVD originating from different molecular causes to understand the cell-matrix biology during disease progression will become increasingly important.
Ultimately, a systems biology-based approach will help to identify critical factors and analyse the complex interactions of diffusible biochemical and ECM signals. However, new biomaterials and technologies will be required to deliver them in an appropriate manner, at the correct dose, place, and time.
Conclusions
Cell culture models provide a high-throughput and highspeed platform on which to study how valvular cells maintain valve homeostasis, mediate disease progression, and respond to external biochemical signals. However, valvular cells need to be cultured in a physiologicallyrelevant matrix environment to improve our understanding of the dynamic crosstalk between cells and the matrix microenvironment. Reconstructing models of normal or diseased valves in vitro, including properties such as appropriate matrix scaffolds and cell architecture has many advantages. For example, they can function as models for drug screening, elucidating mechanisms of disease progression or reversal, and engineering tissue for valve replacement. We believe the field of valve biology is rapidly evolving to take advantage of these new technologies and enables a systems-level understanding of the complex interplay between biochemical signals, the physical matrix, and cell-cell communication. This knowledge will be a critical link for future efforts to direct valvular cell phenotypes and tissue regeneration.
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